Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Pro-Dex Inc.

Start price
Target price
Perf. (%)
€14.00
26.02.23
-
26.02.24
7.86%
27.02.24

StockNews.com 
26.02.23 50%
buy
Trinity Biotech ADR

Start price
Target price
Perf. (%)
€0.99
26.02.23
-
26.02.24
-56.95%
27.02.24

StockNews.com 
26.02.23 50%
buy
Xencor Inc.

Start price
Target price
Perf. (%)
€31.20
26.02.23
-
26.02.24
-21.79%
27.02.24

SVB Leerink LLC 
26.02.23 50%
sell
Advaxis Inc.

Start price
Target price
Perf. (%)
€0.059
26.02.23
-
26.02.24
-
27.02.24

StockNews.com 
26.02.23 50%
sell
iBio Inc.

Start price
Target price
Perf. (%)
€1.21
26.02.23
€0.000
26.02.24
27.85%
04.03.23

Some uniques
Significant cyclical dependencies
Little known brand
Higher risks for its business
kostojunior 
26.02.23 0%
buy
Quoin Pharmaceuticals Ltd. ADR

Start price
Target price
Perf. (%)
€0.65
22.02.23
-
22.02.24
-23.57%
23.02.24

Could be worthwhile Investment >10% per year
Good culture
Capable Management
Few uniques
me8 
22.02.23 0%
buy
UCB S.A.

Start price
Target price
Perf. (%)
€80.98
22.02.23
€95.00
22.02.24
18.18%
23.02.24

Could be worthwhile Investment >10% per year
melinda 
22.02.23 50%
sell
Newron Pharmaceut.

Start price
Target price
Perf. (%)
€7.58
21.02.23
-
21.02.24
-37.99%
24.04.23

Probably not worthwhile Investment
Lokrim 
21.02.23 20%
buy
Orpea Nom.

Start price
Target price
Perf. (%)
€2.58
20.02.23
-
20.02.24
-1.16%
05.03.23

Could be very worthwhile Investment >20% year
Wolf_of_WS 
20.02.23 50%
buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€11.46
16.02.23
-
16.02.24
18.24%
02.04.23

Could be worthwhile Investment >10% per year
Vassago1 
16.02.23 50%
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€4.52
15.02.23
-
15.02.24
53.76%
02.04.23

Could be worthwhile Investment >10% per year
Vassago1 
15.02.23 50%
sell
Inovio Pharma

Start price
Target price
Perf. (%)
€1.47
13.02.23
€0.30
13.02.24
-63.81%
14.02.24

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
13.02.23 50%
buy
Lannett Co. Inc.

Start price
Target price
Perf. (%)
€0.015
13.02.23
€5.20
-
21.02.23

Could be very worthwhile Investment >20% year
DomRuinart 
13.02.23 50%
buy
Evotec SE

Start price
Target price
Perf. (%)
€18.95
09.02.23
-
09.02.24
-25.86%
10.02.24

Erntehelfer 
09.02.23 50%
buy
Orpea Nom.

Start price
Target price
Perf. (%)
€2.17
08.02.23
-
08.02.24
-9.35%
03.04.23

Could be very worthwhile Investment >20% year
bundfuture 
08.02.23 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€58.91
08.02.23
€67.00
08.08.23
-11.76%
08.08.23

Undervalued
Well known brand
Future proof or reliable business model
Top 10 in its market
Snowman 
08.02.23 60%
sell
MyMD Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.04
07.02.23
€1.00
07.02.24
-7.35%
18.02.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
kostojunior 
07.02.23 40%
sell
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€1.58
07.02.23
€1.00
07.02.24
-5.06%
18.02.23

Probably not worthwhile Investment
Below average Management
Bad culture
kostojunior 
07.02.23 40%
buy
Orpea Nom.

Start price
Target price
Perf. (%)
€2.36
07.02.23
€4.00
07.02.24
9.32%
18.02.23

Could be very worthwhile Investment >20% year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
kostojunior 
07.02.23 40%
buy
Eiger Biopharmaceuticals Inc

Start price
Target price
Perf. (%)
€2.10
07.02.23
-
07.03.23
18.88%
10.02.23

Mori8 
07.02.23 50%
buy
Reata Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€47.20
07.02.23
€50.00
07.02.25
100.21%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
07.02.23 70%
buy
MannKind Corp.

Start price
Target price
Perf. (%)
€4.76
07.02.23
-
07.02.24
-35.38%
31.01.24

Saftman 
07.02.23 50%
buy
Actinium Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€11.30
06.02.23
€20.00
31.12.25
-29.20%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
06.02.23 70%
buy
aTyr Pharma Inc

Start price
Target price
Perf. (%)
€2.30
06.02.23
€3.50
31.12.25
-16.01%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
06.02.23 60%
buy
Cytomx Therapeutics Inc

Start price
Target price
Perf. (%)
€2.59
06.02.23
€4.00
31.12.25
-40.15%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
06.02.23 60%